Ebselen: A Multifaceted Organoselenium Compound With Therapeutic Potential in Liver Diseases
Oxidative Medicine and Cellular Longevity · 2026
DOI: 10.1155/omcl/9370771 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oxidative Medicine and Cellular Longevity, 2026. Verfasst von Lujain Bader Eddin und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, P.O. Box 15551, Al Ain, UAE, u…. Hauptthemen laut MEDLINE: Organoselenium Compounds, Azoles, Liver Diseases. Die Arbeit nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United Arab Emirates University.
Abstract (Originalsprache)
Both oxidative stress and inflammation are considered the driving mechanisms in most liver pathologies. Therefore, identifying pharmacological compounds with antioxidant and anti‐inflammatory properties is central to curbing hepatic diseases. Ebselen is a synthetic organoselenium compound with glutathione peroxidase (GPx)‐like activity, demonstrating potent antioxidant and anti‐inflammatory effects experimentally. Ebselen targets several molecular mechanisms involved in hepatic cellular injury. It maintains redox‐sensitive signaling, neutralizes reactive free radicals, and regulates thiol‐dependent enzymes in experimental models of drug‐induced, ischemia‐reperfusion, and metabolic liver diseases. Studies provided experimental evidence for Ebselen’s role in suppressing lipid peroxidation, preserving mitochondrial dynamics, inhibiting inflammatory response, and protecting hepatocytes in cell lines as well as murine models of different liver injuries. Findings also reported an indirect effect on cellular demise and fibrogenesis through inhibiting the activation of hepatic stellate cells (HSCs) and decreasing collagen deposition. The hepatoprotective effects of Ebselen also extend to include reducing hepatic lipid accumulation and preventing steatosis induction in rodent models of liver fibrosis. This review summarizes the current available evidence on the hepatoprotective effects of Ebselen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, P.O. Box 15551, Al Ain, UAE, uaeu.ac.ae.
ORCID-Profile: Lujain Bader Eddin, Shreesh Ojha
Förderung
- United Arab Emirates University
Zitieren
APA
Bader Eddin, L., & Ojha, S. (2026). Ebselen: A Multifaceted Organoselenium Compound With Therapeutic Potential in Liver Diseases. Oxidative Medicine and Cellular Longevity. https://doi.org/10.1155/omcl/9370771
Vancouver
Bader Eddin L, Ojha S. Ebselen: A Multifaceted Organoselenium Compound With Therapeutic Potential in Liver Diseases. Oxidative Medicine and Cellular Longevity. 2026. doi:10.1155/omcl/9370771
BibTeX
@article{BaderEddin2026,
author = {Bader Eddin, Lujain and Ojha, Shreesh},
title = {Ebselen: A Multifaceted Organoselenium Compound With Therapeutic Potential in Liver Diseases},
journal = {Oxidative Medicine and Cellular Longevity},
year = {2026},
doi = {10.1155/omcl/9370771}
}
EUVIMED